Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CRAY, PETX SHAREHOLDER CLASS ACTIONS: Halper Sadeh LLP Announces Shareholder Class Actions Against Cray Inc. And Aratana Therapeutics, Inc. - CRAY, PETX

NEW YORK, NY / ACCESSWIRE / June 24, 2019 / Halper Sadeh LLP, a global investor rights law firm, announces the filing of shareholder class action lawsuits against Cray Inc. (NASDAQ: CRAY) and Aratana Therapeutics, Inc. (NASDAQ: PETX) in connection with the sale of these respective companies. The lawsuits each seek equitable relief and/or damages on behalf of the shareholders of these companies.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Cray Inc. (NASDAQ:CRAY)

According to the lawsuit, Defendants issued materially incomplete disclosures in connection with the proposed sale of Cray to Hewlett Packard Enterprise. Specifically, the complaint alleges that Defendants omitted material information concerning: (1) the sales process leading up to the proposed transaction; (2) the financial projections prepared by Cray management; and (3) the financial analyses conducted by Cray's financial advisor. To learn more about your legal rights and options, or to join the action, please visit: CrayMerger or https://halpersadeh.com/actions/cray-inc-merger-hewlett-packard-stock/.

AratanaTherapeutics, Inc. (NASDAQ: PETX)

According to the lawsuit, Defendants issued materially incomplete disclosures in connection with the proposed sale of Aratana to Elanco Animal Health. Specifically, the complaint alleges that Defendants omitted material information concerning: (1) Aratana's and Elanco's financial projections; (2) the financial analyses performed by Aratana's financial advisor; and (3) the sales process leading up to the proposed transaction. To learn more about your legal rights and options, or to join the action, please visit: AratanaMerger or https://halpersadeh.com/actions/aratana-therapeutics-inc-petx-merger-elanco-stock/.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP



View source version on accesswire.com:
https://www.accesswire.com/549747/CRAY-PETX-SHAREHOLDER-CLASS-ACTIONS-Halper-Sadeh-LLP-Announces-Shareholder-Class-Actions-Against-Cray-Inc-And-Aratana-Therapeutics-Inc--CRAY-PETX